North America

EDGe Surgical Secures $1.3M+ to Drive Growth and Product Expansion

Funding to Fuel Commercial Scale-Up and Launch of New Ortho EDG Surgical Instruments in U.S. and International Markets....

Teal Health’s Teal Wand™ Receives FDA Approval as First At-Home Cervical Cancer Screening Device

Breakthrough self-collection technology offers women a more comfortable, accessible alternative to traditional in-clinic screenings, aiming to boost early detection and public health outcomes. ...

OmniAb Launches xPloration® Partner Access Program to Accelerate Antibody Discovery Collaborations

New initiative aims to provide early-stage biotech and academic partners with greater access to OmniAb’s antibody discovery technologies, supporting innovation and therapeutic development. ...

Covera Health Expands Radiology Centers of Excellence with Prostate MRI Integration

New addition boosts diagnostic accuracy in prostate cancer care, strengthening Covera’s imaging quality program across U.S. healthcare networks...

Glytec Wins 2025 MedTech Breakthrough Award for Best Clinical Decision Support

Award Highlights Glytec’s Leadership in Advancing Safe, Effective Insulin Management Through Innovative Software Solutions...

SS Innovations to File FDA Application for Robotic Surgery System

SSi Mantra 3 robotic system moves toward FDA clearance for multispecialty use. ...

Carta Healthcare Secures $18.25M to Advance AI-Driven Clinical Data Solutions

Series B1 Funding to Scale AI-Powered Data Abstraction and Analytics Across U.S. Healthcare Systems...

Lipogems Completes ARISE I Clinical Trial for Knee Osteoarthritis

Final patient visit marks major milestone in FDA IDE study, advancing treatment options for patients not eligible for knee replacement....

FastWave Medical Secures IRB Approval for Sola™ Coronary Laser IVL System

Breakthrough intravascular lithotripsy device to begin first-in-human trials for treatment of calcified coronary artery disease...

Aspen Neuroscience Reports Positive 6-Month Results from ASPIRO Trial for Parkinson's Cell Therapy

Personalized iPSC-derived dopaminergic neuron therapy shows early signs of safety and potential benefit in first-in-human study...